RMD - Why ResMed Shares Are Trading Lower Monday | Benzinga
ResMed, Inc. (NYSE:RMD) stock is trading lower Monday after Eli Lilly and Company (NYSE:LLY) released data from a clinical trial in regards to the treatment of sleep apnea.
The Details: Lilly released data on Friday from its SURMOUNT-OSA phase 3 clinical trial which tested tirzepatide as a treatment for obstructive sleep apnea. This could present a potential ...